1. KD. Tripathi. Autocoids and related drugs & Drugs for Cough and Bronchial Asthma. Essentials of medical pharmacology. Seventh edition. 2013. Page – 166-169 & 228-229.
2. Randal A. Skidgel, Allen P. Kaplan and Ervin G. Erdos. Histamine, Bradykinin and their antagonists. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 920-924.
3. Gerald G. Briggs and Roger K. & M. Freeman. F. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 1555-1556 & 2629-2632.
4. Indira Gandhi Medical College, Shimla. Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in September 2015] [Accessed on 23rd August 2021] https://clinicaltrials.gov/ct2/show/NCT02551536
5. Sanofi. Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in January 2011] [Accessed on 23rd August 2021] https://clinicaltrials.gov/ct2/show/NCT00638118
6. Mohini Sachin Mahatme, Ganesh Natthuji Dakhale, Kanchan Tadke, Sachin Keshaorao Hiware, S. D. Dudhgaonkar, and Sumit Wankhede. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial. NCBI; PMC US National Library of Medicine, National Institute of Health. November – December 2016. [Accessed on 23rd August 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155464/
7. Cipla Ltd. Montair FX Tablets (Montelukast sodium + Fexofenadine hydrochloride). Ciplamed. [Revised in March 2016] [Accessed on 23rd August 2021] https://www.ciplamed.com/content/montair-fx-tablets
8. Sanofi India Limited. Allegra M Tablets. Sanofi.in. [Revised in February 2019] [Accessed on 23rd August 2021] https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/Allegra-M---PI.pdf
9. Sanofi India Limited. Sanofi.in. [Revised in May 2020] [Accessed on 23rd August 2021] https://www.sanofi.in/-/media/Project/One-Sanofi-Web/Websites/Asia-Pacific/Sanofi-IN/Home/science-and-innovation/for-healthcare-professionals/product-information/Allegra-PI.pdf?la=en
10. Dr. Reddy’s Laboratories (UK) Ltd. Electronic Medicines Compendium (EMC). [Revised in August 2018] [Accessed on 23rd August 2021] https://www.medicines.org.uk/emc/files/pil.3487.pdf
11. Merck Sharp & Dohme Limited. Electronic Medicines Compendium (EMC). [Revised in May 2020] [Accessed on 23rd August 2021] https://www.medicines.org.uk/emc/files/pil.198.pdf
12. Merck & Co., Inc. U.S. Food & Drug Administration. [Revised in March 2012] [Accessed on 23rd August 2021] https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021409s036lbl.pdf